Long-term efficacy and safety of larotrectinib in a pooled analysis of patients with tropomyosin receptor kinase (TRK) fusion cancer Meeting Abstract
| Authors: | Drilon, A. E.; Hong, D. S.; Van Tilburg, C. M.; Doz, F.; Tan, D. S. W.; Kummar, S.; Lin, J. J.; McDermott, R. S.; Zwaan, C. M.; Norenberg, R.; Fellous, M. M.; Brega, N.; Xu, R. H.; Laetsch, T. W.; Shen, L. |
| Abstract Title: | Long-term efficacy and safety of larotrectinib in a pooled analysis of patients with tropomyosin receptor kinase (TRK) fusion cancer |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680300993 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.3100 |
| Notes: | Meeting Abstract: 3100 -- This meeting was also held virtually -- Source: Wos |
